Summary
GlobalData's clinical trial report, “Hypocobalaminemia (Vitamin B12) Deficiency Global Clinical Trials Review, H2, 2018" provides an overview of Hypocobalaminemia (Vitamin B12) Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Hypocobalaminemia (Vitamin B12) Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Troikaa Pharmaceuticals Ltd
Uni Research AS
Viridis Biopharma Pvt Ltd
Raptim Research LTD
Phoenix Srl
International Centre for Diarrhoeal Disease Research Bangladesh
Emisphere Technologies Inc
Eisai Co Ltd
Arbro Pharmaceuticals Pvt Ltd
Aarelab AG
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Hypocobalaminemia (Vitamin B12) Deficiency to Nutritional Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Hypocobalaminemia (Vitamin B12) Deficiency to Nutritional Disorders Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profile Snapshots 36
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 65
Contact Us 66
Source 66
List of Tables
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials by Region, 2018* 7
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Hypocobalaminemia (Vitamin B12) Deficiency to Nutritional Disorders Clinical Trials, G7 Countries (%), 2018* 17
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Hypocobalaminemia (Vitamin B12) Deficiency to Nutritional Disorders Clinical Trials, E7 Countries (%), 2018* 21
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials by Phase, 2018* 24
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
List of Figures
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Proportion of Hypocobalaminemia (Vitamin B12) Deficiency to Nutritional Disorders Clinical Trials, G7 Countries (%), 2018* 16
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Hypocobalaminemia (Vitamin B12) Deficiency to Nutritional Disorders Clinical Trials, E7 Countries (%), 2018* 20
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Hypocobalaminemia (Vitamin B12) Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
GlobalData Methodology 65
